(Q37398576)

20 August 2017

1 reference

title

The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease (English)

1 reference

20 August 2017

0 references

arterial hypertension

0 references

interleukins

0 references

author name string

Simon W Rabkin

series ordinal

1

1 reference

20 August 2017

1 March 2009

1 reference

Nature Clinical Practice Cardiovascular Medicine

20 August 2017

1 reference

20 August 2017

6

1 reference

20 August 2017

3

1 reference

20 August 2017

192-199

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpcardio1453

20 August 2017

0 references

cites work

Autoradiographic study of smooth muscle cell proliferation in spontaneously hypertensive rats.

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNCPCARDIO1453

Replication of smooth muscle cells in vascular disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNCPCARDIO1453

Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction

21 January 2018

1 reference

12 December 2020

Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

1 reference

12 December 2020

The structure and binding mode of interleukin-18

1 reference

12 December 2020

Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension

1 reference

12 December 2020

Small artery structure and hypertension: adaptive changes and target organ damage

1 reference

12 December 2020

Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk

1 reference

12 December 2020

Interleukin-18 primes the oxidative burst of neutrophils in response to formyl-peptides: role of cytochrome b558 translocation and N-formyl peptide receptor endocytosis

1 reference

12 December 2020

The potential anti-inflammatory benefits of improving physical fitness in hypertension

1 reference

12 December 2020

Interleukin-18 levels are not associated with subclinical carotid atherosclerosis in a community population. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).

1 reference

12 December 2020

Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6.

1 reference

12 December 2020

Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease

1 reference

12 December 2020

NADPH oxidase inhibitors: new antihypertensive agents?

1 reference

12 December 2020

Oxidative-nitrosative stress in hypertension

1 reference

12 December 2020

Is adrenaline the cause of essential hypertension?

1 reference

12 December 2020

Redox signaling in hypertension

1 reference

12 December 2020

Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death

1 reference

12 December 2020

The association of interleukin-18 genotype and serum levels with metabolic risk factors for cardiovascular disease

1 reference

12 December 2020

Beta-adrenergic stimulation induces interleukin-18 expression via beta2-AR, PI3K, Akt, IKK, and NF-kappaB.

1 reference

12 December 2020

Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy

1 reference

12 December 2020

Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment

1 reference

12 December 2020

Reactive oxygen species signaling in vascular smooth muscle cells

1 reference

12 December 2020

Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis

1 reference

12 December 2020

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

1 reference

12 December 2020

Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea.

1 reference

12 December 2020

The nitric oxide donor DETA-NONOate decreases matrix metalloproteinase-9 expression and activity in rat aortic smooth muscle and abdominal aortic explants

1 reference

12 December 2020

Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production.

1 reference

12 December 2020

Matrix Metalloproteinase-2 and −9 Differentially Regulate Smooth Muscle Cell Migration and Cell-Mediated Collagen Organization

1 reference

12 December 2020

1 reference

12 December 2020

Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Inflammation biomarkers and near-term death in older men.

1 reference

12 December 2020

Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension

1 reference

12 December 2020

Control of matrix metalloproteinase catalytic activity

1 reference

12 December 2020

Interleukin-18 regulates both Th1 and Th2 responses

1 reference

12 December 2020

Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice

1 reference

12 December 2020

The pro-atherogenic cytokine interleukin-18 induces CXCL16 expression in rat aortic smooth muscle cells via MyD88, interleukin-1 receptor-associated kinase, tumor necrosis factor receptor-associated factor 6, c-Src, phosphatidylinositol 3-kinase, Ak

1 reference

12 December 2020

Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus

1 reference

12 December 2020

Purification and characterization of the human interleukin-18 receptor

1 reference

12 December 2020

Epicardial fat: properties, function and relationship to obesity

1 reference

12 December 2020

Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).

1 reference

12 December 2020

Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction

1 reference

12 December 2020

Associations of serum IL-18 levels with carotid intima-media thickness

1 reference

12 December 2020

Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance.

1 reference

12 December 2020

Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study

1 reference

12 December 2020

The 'adrenaline hypothesis' of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension

1 reference

12 December 2020

Physiological levels of interleukin-18 stimulate multiple neutrophil functions through p38 MAP kinase activation.

1 reference

12 December 2020

Signaling through beta-catenin and Lef/Tcf

1 reference

12 December 2020

Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells

1 reference

12 December 2020

Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis

1 reference

12 December 2020

Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes

1 reference

12 December 2020

Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients

1 reference

12 December 2020

Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis

1 reference

12 December 2020

The sympatho-adrenal tone and reactivity in human hypertension.

1 reference

12 December 2020

Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study.

1 reference

12 December 2020

C-reactive protein and interleukin-18 levels in relation to coronary heart disease: prospective cohort study from Busselton Western Australia

1 reference

12 December 2020

Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness

1 reference

12 December 2020

Matrix Metalloproteinase-2, -9, and Tissue Inhibitor of Metalloproteinase-1 in Patients with Hypertension

1 reference

12 December 2020

Interleukin-18 genetics and inflammatory disease susceptibility

1 reference

12 December 2020

Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002.

1 reference

12 December 2020

Interleukin-18 and macrophage migration inhibitory factor are associated with increased carotid intima-media thickening.

1 reference

12 December 2020

Interleukin-18 induces human cardiac endothelial cell death via a novel signaling pathway involving NF-kappaB-dependent PTEN activation

1 reference

12 December 2020

IL-18: relationship with anthropometry, body composition parameters, leptin and arterial hypertension

1 reference

12 December 2020

Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey

1 reference

12 December 2020

Aldosterone induces interleukin-18 through endothelin-1, angiotensin II, Rho/Rho-kinase, and PPARs in cardiomyocytes

1 reference

12 December 2020

Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke

1 reference

12 December 2020

Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension

1 reference

12 December 2020

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy

1 reference

12 December 2020

Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin

1 reference

12 December 2020

Relationship between adiposity and body size reveals limitations of BMI.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NCPCARDIO1453

1 reference

PubMed ID

19234499

Dimensions Publication ID

20 August 2017

0 references

1 reference

PubMed ID

19234499